These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37189276)
1. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population. Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276 [TBL] [Abstract][Full Text] [Related]
2. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort. Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769 [TBL] [Abstract][Full Text] [Related]
3. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population]. Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144 [TBL] [Abstract][Full Text] [Related]
4. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China. Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590 [TBL] [Abstract][Full Text] [Related]
5. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683 [TBL] [Abstract][Full Text] [Related]
6. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort. Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study. Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823 [TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older. Wang Z; Yang X; Li L; Zhang X; Zhou W; Chen S Clin Interv Aging; 2024; 19():529-538. PubMed ID: 38525315 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease. Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056 [TBL] [Abstract][Full Text] [Related]
11. Comparing the performance of machine learning and conventional models for predicting atherosclerotic cardiovascular disease in a general Chinese population. Fan Z; Du Z; Fu J; Zhou Y; Zhang P; Shi C; Sun Y BMC Med Inform Decis Mak; 2023 Jul; 23(1):134. PubMed ID: 37488520 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population. Al-Shamsi S BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study. Honda T; Chen S; Hata J; Yoshida D; Hirakawa Y; Furuta Y; Shibata M; Sakata S; Kitazono T; Ninomiya T J Atheroscler Thromb; 2022 Mar; 29(3):345-361. PubMed ID: 33487620 [TBL] [Abstract][Full Text] [Related]
14. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study. Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697 [TBL] [Abstract][Full Text] [Related]
15. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017. Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424 [TBL] [Abstract][Full Text] [Related]
16. Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis. Qian X; Keerman M; Zhang X; Guo H; He J; Maimaitijiang R; Wang X; Ma J; Li Y; Ma R; Guo S BMC Public Health; 2023 Jun; 23(1):1041. PubMed ID: 37264356 [TBL] [Abstract][Full Text] [Related]
17. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study. Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576 [TBL] [Abstract][Full Text] [Related]
18. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216 [TBL] [Abstract][Full Text] [Related]
19. Prediction of 8-year risk of cardiovascular diseases in Korean adult population. Choi SH; Lee SM; Kim SH; Park M; Yoon HJ Sci Rep; 2021 Jul; 11(1):14339. PubMed ID: 34253829 [TBL] [Abstract][Full Text] [Related]